Tuesday, October, 15, 2019 05:11:09

Global erdosteine market trends is escalating demands for mucus regulating medicines due to the rising level of air pollution. Erdosteine is an active pharmaceutical ingredient that is used to manufacture drugs that alleviate cold symptoms by making mucus less viscous and sticky and opening up airways.

Rising disposable income levels and changing lifestyles are driving the smoking trend in emerging APAC economies such as India, Indonesia and China. Chronic smoking has been linked to accelerated mucus production due to diseases like chronic bronchitis and smokers cough.

Moreover, smoking also has a detrimental effect on cilia, which is crucial for healthy movement of mucus to the throat. The destruction of cilia causes mucus to accumulate in the bronchioles, causing it to thicken overtime, leading to throat irritation and coughing.

These symptoms associated with smoking are expected to boost erdosteine market outlook across the region significantly, particularly through cough and cold clearing drugs in coming years.

Air pollution caused by factories and internal combustion engine (ICE) based vehicles emit a variety of contaminants like carbon and other toxic gases to the atmosphere. Similar to smoking, air pollution plays a major role in causing common respirator problems like cold, cough, and bronchitis.

To access a sample copy or view the erdosteine market report in detail along with the table of contents, please click the link below:  https://www.gminsights.com/request-sample/detail/3371

In fact, deteriorating air quality is responsible for causing a majority of the aforementioned respiratory problems. Attributing to this factor, countries that experience high levels of air pollution are expected to further drive erdosteine market expansion during the forecast timeframe.

Apart from man-made pollution, other air contaminants such as dust and pollen are also responsible for boosting mucus buildup, predominantly through allergic reactions. This is further expected to introduce additional revenue sources to the erdosteine market in coming years.

Increasing in clinical research funding across several top universities in Europe and U.S. such as John Hopkins University, Harvard Medical School, Yale School of Medicine, and Stanford Medicine is slated to foster market growth in forthcoming years.

These investments are fueling various clinical trials in these universities, which are actively trying to quantify and qualify the overall efficacy of erdosteines-based drugs in cardiovascular and respiratory diseases, further promoting erdosteines market growth during the forecast timeframe.

All in all, it is projected that the growth of respiratory diseases caused by air pollution and smoking would be augmenting demand for erdosteine over the coming years. Research reports suggest that the global erdosteine market size would be surpassing $150 million valuation by 2025.


 About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: [email protected]

Web: https://www.gminsights.com